Altered macrophagic THP-1 cell phagocytosis and migration in bisphosphonate-related osteonecrosis of the jaw (BRONJ)

Infection and Medication-related Osteonecrosis of the Jaw

(2015) H. Katsarelis et al.   JOURNAL OF DENTAL RESEARCH

Important aspects regarding the role of microorganisms in bisphosphonate-related osteonecrosis of the jaws

(2014) Renata Chiapinotto Boff et al.   ARCHIVES OF ORAL BIOLOGY

Zoledronate but not denosumab suppresses macrophagic differentiation of THP-1 cells. An aetiologic model of bisphosphonate-related osteonecrosis of the jaw (BRONJ)

(2014) Sebastian Hoefert et al.   Clinical Oral Investigations

In vitro effects of bisphosphonates on chemotaxis, phagocytosis, and oxidative burst of neutrophil granulocytes

(2014) Nadine Hagelauer et al.   Clinical Oral Investigations

Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases

(2014) Sebastian Hoefert et al.   Clinical Oral Investigations

Generation of membrane structures during phagocytosis and chemotaxis of macrophages: role and regulation of the actin cytoskeleton

(2014) Pablo Rougerie et al.   IMMUNOLOGICAL REVIEWS

THP-1 cell line: An in vitro cell model for immune modulation approach

(2014) Wasaporn Chanput et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update

(2014) Salvatore L. Ruggiero et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Modulation of Osteoclastogenesis with Macrophage M1- and M2-Inducing Stimuli

(2014) Sujeeve Jeganathan et al.   PLoS One

The effect of bisphosphonate therapy on neutrophil function: a potential biomarker

(2013) C.L. Favot et al.   INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Differential Uptake of Functionalized Polystyrene Nanoparticles by Human Macrophages and a Monocytic Cell Line

(2011) Oleg Lunov et al.   ACS Nano

Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases

(2011) F. Saad et al.   ANNALS OF ONCOLOGY

The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature

(2011) Zhenyu Qin   ATHEROSCLEROSIS

Bisphosphonates: The first 40years

(2011) R. Graham G. Russell   BONE

Zoledronate and pamidronate depress neutrophil functions and survival in mice

(2011) JWP Kuiper et al.   BRITISH JOURNAL OF PHARMACOLOGY

Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis

(2011) Keiichiro Kimachi et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

(2010) Alison T. Stopeck et al.   JOURNAL OF CLINICAL ONCOLOGY

Bisphosphonate-Related Osteonecrosis of the Jaw: Is pH the Missing Part in the Pathogenesis Puzzle?

(2010) Sven Otto et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Osteonecrosis of the Jaw and the Role of Macrophages

(2010) M. Pazianas   JNCI-Journal of the National Cancer Institute

Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings

(2009) Sebastian Hoefert et al.   Clinical Oral Investigations

Bisphosphonates—What the Dentist Needs to Know: Practical Considerations

(2009) John E. Fantasia   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy

(2008) R. G. G. Russell et al.   OSTEOPOROSIS INTERNATIONAL